Press Release: Tivic Reports Fiscal Year 2023 Financial Results

Dow Jones03-26

STOCKHOLDERS' EQUITY 
   Common stock                               --                   -- 
   Additional paid in 
    capital                               41,466               33,272 
   Accumulated deficit                   (37,886)             (29,642) 
                                  --------------       -------------- 
TOTAL STOCKHOLDERS' EQUITY                 3,580                3,630 
                                  --------------       -------------- 
TOTAL LIABILITIES AND 
 STOCKHOLDERS' EQUITY         $            5,157   $            5,875 
                                  ==============       ============== 
 
 
Tivic Health Systems, Inc. 
Condensed Statements of Operations 
(in thousands, except share and per share data) 
------------------------------------------------------------------------ 
 
                                             Year Ended December 31, 
                                             2023             2022 
                                         -------------      --------- 
REVENUES                                 $       1,176      $   1,840 
COST OF SALES                                      889          1,541 
                                             ---------       -------- 
GROSS PROFIT                                       287            299 
OPERATING EXPENSES 
   Research and development                      1,655          1,730 
   Sales and marketing                           2,125          2,792 
   General and administrative                    4,752          5,875 
                                             ---------       -------- 
TOTAL OPERATING EXPENSES                         8,532         10,397 
                                             ---------       -------- 
NET OPERATING LOSS                              (8,245)       (10,098) 
                                             ---------       -------- 
NET LOSS                                 $      (8,244)     $ (10,096) 
                                             =========       ======== 
NET LOSS PER SHARE - BASIC AND DILUTED   $      (10.40)     $ (104.32) 
WEIGHTED-AVERAGE NUMBER OF SHARES - 
 BASIC AND DILUTED                             793,043         96,778

View source version on businesswire.com: https://www.businesswire.com/news/home/20240325512073/en/

 
    CONTACT:    Investor Contact:

Hanover International, Inc.

ir@tivichealth.com

(END) Dow Jones Newswires

March 25, 2024 17:25 ET (21:25 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Press Release: Tivic Reports Fiscal Year 2023 Financial Results

Comments